You are here

Magazine

17

A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis.

Allegrini A et al.

“A clinical trial recently published assessed the efficacy, safety and tolerability of a xyloglucan-based nasal spray (Rhinosectan) in the treatment of rhinosinusitis, and concluded that this medical device provided greater relief of symptoms than a physiological saline spray”. Allegrini A et al. A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis. Current Medical Research and Opinion, 2017. DOI: 0.1080/03007995.2017.1341402

Read more

New publication on Tasectan Duo

L. Lopetuso, C. Graziani, A. Guarino, A. Lamborghini, S. Masi, V. Stanghellini

Eur Rev Med Pharmacol Sci . 2017; 21 (4): 873-883Researchers from the A. Gemelli Foundation, School of Medicine, Rome, Italy have published an extensive review on the role of Gelatin tannate and tyndallized probiotics (Tasectan Duo) in the treatment of diarrhea.https://www.ncbi.nlm.nih.gov...

Read more

Let's meet in..

2021, Nov 09

CPhI 2021

Read more

2021, Nov 22

EuroPLX 77 Brussels

Read more

2022, Feb 01

EWMA

Read more